Publication | Open Access

Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease

Metabolic SyndromeThrombosisVascular DiseaseCardiovascular DiseaseFunction AllelesEndovascular TreatmentVascular SurgeryPathologyVascular BiologyArterial DiseaseCyp2c19 LossMedicineAtherosclerosisPeripheral Artery DiseasePeripheral Vascular Disease